Clinical Trial Update: Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5 [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study assessing how dialysis impacts telavancin clearance in patients with end-stage renal disease (chronic kidney disease, stage 5); re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease Stage
• End-stage Renal Disease

Drugs mentioned

• Telavancin (telavancin)

Snippet

Sponsor: University of Michigan | Conditions: End-Stage Renal Disease, Stage 5 Chronic Kidney Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-03-30